Latest Content

High-risk essential thrombocythemia is manageable with treatment focused on preventing blood clots and maintaining safe platelet levels.

After a liver cancer diagnosis, one son stepped forward as a living donor, turning uncertainty into hope through a life-saving decision.

Functional precision medicine uses a patient’s tumor cells to test drugs, helping guide more personalized brain tumor treatment decisions.

Study shows home-based IV chemotherapy at Mayo Clinic was safely delivered with close monitoring, reducing treatment burden for patients with cancer.

Metastatic breast cancer survivor Casey Liening shares her adoption story in a candid interview.

FDA approves Opdivo with AVD for stage 3 or 4 Hodgkin lymphoma after trial shows improved progression-free survival versus comparator in untreated patients.

A couple shares how open communication reshaped their relationship during and after liver cancer treatment.

We often face difficult decisions with patients and family members. Are the side effects of treatment worth the benefits? Is cure achievable, and at what cost?

For Kathy Small Wrice, a 20-year journey with multiple myeloma began not with a clear answer, but with a persistent intuition.

Shondia McFadden-Sabari of Bold and Breastless shares how intuition and early detection saved her life during a dual breast cancer diagnosis.

Talzenna plus Xtandi improved progression-free survival in metastatic prostate cancer, delaying disease worsening in a phase 3 trial.

New strategies in mCRPC focus on sequencing, genomics and earlier use of targeted therapies to improve outcomes for patients.

A phase 3 study shows pimicotinib shrinks tumors and improves pain, stiffness and mobility in adults with unresectable tenosynovial giant cell tumors.